Lawrence S Gaines1,2, James C Slaughter3, David A Schwartz1, Dawn B Beaulieu1, Sara N Horst1, Robin L Dalal1, Elizabeth A Scoville1, Robert S Sandler4, Michael D Kappelman5. 1. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Nashville, Tennessee, USA. 2. Division of Psychology, Department of Psychiatry and Behavioral Science, Nashville, Tennessee, USA. 3. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 4. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Chapel Hill, North Carolina, USA. 5. Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
Abstract
BACKGROUND: Studies suggest that there is a temporal relationship between depression and Crohn's disease (CD) activity. However, these studies assumed a unidirectional relationship and did not examine the possibility of reverse causality and the risk of a spurious association due to the overlap of symptoms underlying the depression-CD relationship. We evaluated the existence of reverse causality reflected in a possible bidirectional relationship between patient-reported CD activity and an affective-cognitive dimension of depression. METHODS: We studied 3307 adult volunteers with a self-reported diagnosis of CD who completed a baseline survey that included demographics, CD activity, and an affective-cognitive index of depression. Crohn's disease status and the affective-cognitive index of depression were also measured 6 and 12 months after the baseline evaluation. We used structural equation models to evaluate whether the effect of depression on future CD activity is stronger than the effect of CD activity on future depression. We calculated the likelihood that each of these hypotheses is supported by the data and calculated the likelihood ratio to provide a relative measure of which hypothesis best accounts for the data. RESULTS: The results of the informative hypothesis testing showed the most support for the hypothesis stating that an affective-cognitive dimension of depression is a stronger predictor of patient-reported CD activity than the converse. CONCLUSIONS: The hypothesis that an affective-cognitive dimension of depression predicts patient-reported exacerbation of CD is 218 times more likely to account for the data than the converse.
BACKGROUND: Studies suggest that there is a temporal relationship between depression and Crohn's disease (CD) activity. However, these studies assumed a unidirectional relationship and did not examine the possibility of reverse causality and the risk of a spurious association due to the overlap of symptoms underlying the depression-CD relationship. We evaluated the existence of reverse causality reflected in a possible bidirectional relationship between patient-reported CD activity and an affective-cognitive dimension of depression. METHODS: We studied 3307 adult volunteers with a self-reported diagnosis of CD who completed a baseline survey that included demographics, CD activity, and an affective-cognitive index of depression. Crohn's disease status and the affective-cognitive index of depression were also measured 6 and 12 months after the baseline evaluation. We used structural equation models to evaluate whether the effect of depression on future CD activity is stronger than the effect of CD activity on future depression. We calculated the likelihood that each of these hypotheses is supported by the data and calculated the likelihood ratio to provide a relative measure of which hypothesis best accounts for the data. RESULTS: The results of the informative hypothesis testing showed the most support for the hypothesis stating that an affective-cognitive dimension of depression is a stronger predictor of patient-reported CD activity than the converse. CONCLUSIONS: The hypothesis that an affective-cognitive dimension of depression predicts patient-reported exacerbation of CD is 218 times more likely to account for the data than the converse.
Authors: Millie D Long; Michael D Kappelman; Christopher F Martin; James D Lewis; Lloyd Mayer; Patricia M Kinneer; Robert S Sandler Journal: Inflamm Bowel Dis Date: 2012-01-27 Impact factor: 5.325
Authors: Kelvin Thia; William A Faubion; Edward V Loftus; Tore Persson; Anders Persson; William J Sandborn Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325
Authors: Rachel L Randell; Millie D Long; Suzanne F Cook; Christina E D Wrennall; Wenli Chen; Christopher F Martin; Kristen Anton; Robert S Sandler; Michael D Kappelman Journal: Inflamm Bowel Dis Date: 2014-03 Impact factor: 5.325
Authors: Kathryn A Sexton; John R Walker; Lesley A Graff; Matthew T Bernstein; Brooke Beatie; Norine Miller; Michael Sargent; Laura E Targownik Journal: Inflamm Bowel Dis Date: 2017-03 Impact factor: 5.325
Authors: Clarence K Zhang; Jennifer Hewett; Jason Hemming; Taneisha Grant; Hongyu Zhao; Clara Abraham; Ioannis Oikonomou; Meera Kanakia; Judy H Cho; Deborah D Proctor Journal: Inflamm Bowel Dis Date: 2013-07 Impact factor: 5.325